These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2491943)

  • 1. Pharmacokinetics of valproate in adults after a single loading dose.
    Giroud M; Dumas R
    Arch Neurol; 1989 Jan; 46(1):13-4. PubMed ID: 2491943
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of childhood epilepsy with rectal valproate: case reports and pharmacokinetic study.
    Kanazawa O; Sengoku A; Kawai I
    Brain Dev; 1987; 9(6):615-20. PubMed ID: 3128135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single dose and steady state pharmacokinetics of valproic acid in adult epileptic patients.
    Miljković B; Pokrajac M; Varagić V; Lević Z
    Int J Clin Pharmacol Res; 1991; 11(3):137-41. PubMed ID: 1809700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronopharmacokinetic study of valproic acid in man: comparison of oral and rectal administration.
    Yoshiyama Y; Nakano S; Ogawa N
    J Clin Pharmacol; 1989 Nov; 29(11):1048-52. PubMed ID: 2513338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood level profile of valproate administration under therapeutic conditions in children].
    Meyer FP; Sauer I; Staemmler U; Walther H
    Padiatr Grenzgeb; 1990; 29(4):325-30. PubMed ID: 2216528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of pharmacokinetic interactions between steady-state zonisamide and valproic acid in patients with epilepsy.
    Ragueneau-Majlessi I; Levy RH; Brodie M; Smith D; Shah J; Grundy JS
    Clin Pharmacokinet; 2005; 44(5):517-23. PubMed ID: 15871637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and clinical application of intravenous valproate in Thai epileptic children.
    Visudtibhan A; Bhudhisawadi K; Vaewpanich J; Chulavatnatol S; Kaojareon S
    Brain Dev; 2011 Mar; 33(3):189-94. PubMed ID: 20444563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption of valproic acid suppositories in human volunteers.
    Holmes GB; Rosenfeld WE; Graves NM; Remmel RP; Carlson GH; Kriel RD
    Arch Neurol; 1989 Aug; 46(8):906-9. PubMed ID: 2502974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in pharmaceutical development presentation with improved pharmacokinetics: a new formulation for valproate.
    Genton P
    Acta Neurol Scand Suppl; 2005; 182():26-32. PubMed ID: 16359430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral rapid loading of valproic acid--an alternative to the usual saturation scheme?
    Gerstner T; Bell N; Longin E; König SA
    Seizure; 2006 Dec; 15(8):630-2. PubMed ID: 17070075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic interaction of brivaracetam on carbamazepine in adult patients with epilepsy, with and without valproate co-administration.
    Stockis A; Sargentini-Maier ML; Brodie MJ
    Epilepsy Res; 2016 Dec; 128():163-168. PubMed ID: 27842261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of epilepsy. Superiority of a single daily dose of sodium valproate over fractionated doses].
    Giroud M; Dumas M; Escousse A; Dumas R
    Presse Med; 1988 Sep; 17(30):1544. PubMed ID: 2971952
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of valproic acid after administration of three oral formulations in healthy adults.
    Bano G; Gupta S; Gupta KL; Raina RK
    J Assoc Physicians India; 1990 Sep; 38(9):629-30. PubMed ID: 2266076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid infusion with valproate sodium is well tolerated in patients with epilepsy.
    Wheless JW; Vazquez BR; Kanner AM; Ramsay RE; Morton L; Pellock JM
    Neurology; 2004 Oct; 63(8):1507-8. PubMed ID: 15505177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of carbamazepine and valproate in children and adolescents with epilepsy.
    Galas-Zgorzalewicz B; Kluczyński A; Steinborn B
    Neurol Neurochir Pol; 1996; 30 Suppl 2():49-54. PubMed ID: 9100243
    [No Abstract]   [Full Text] [Related]  

  • 16. Valproate toxicity: risk-screening strategies.
    Willmore LJ; Triggs WJ; Pellock JM
    J Child Neurol; 1991 Jan; 6(1):3-6. PubMed ID: 2002198
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravenous valproate dosing in neonates.
    Alfonso I; Alvarez LA; Gilman J; Dunoyer C; Yelin K; Papazian O
    J Child Neurol; 2000 Dec; 15(12):827-9. PubMed ID: 11198504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population Pharmacokinetics of Valproic Acid in Patients with Mania: Implication for Individualized Dosing Regimens.
    Methaneethorn J
    Clin Ther; 2017 Jun; 39(6):1171-1181. PubMed ID: 28483293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic interaction between valproic acid and phenobarbital.
    Pokrajac M; Miljković B; Varagić VM; Lević Z
    Biopharm Drug Dispos; 1993 Jan; 14(1):81-6. PubMed ID: 8427947
    [No Abstract]   [Full Text] [Related]  

  • 20. Steady-state pharmacokinetic simulation of intermittent vs. continuous infusion valproic acid therapy in non-critically ill and critically ill patients.
    Van Matre ET; Cook AM
    Neurol Res; 2016 Sep; 38(9):786-91. PubMed ID: 27414414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.